Keytruda

Made by

• MSD

Active Ingredient

Pembrolizumab

Prospectus

Approval date

2016/9/28

Treats

• Hodgkin lymphoma
• Solid tumor
• Melanoma
• Renal cell carcinoma
• Bladder cancer
• Non-small cell lung cancer
• Head and neck cancer
• Esophageal cancer

Dosages

• KEYTRUDA Injection 100mg - 214498円／瓶